COVID-19 Project Team: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 29: | Line 29: | ||
*[[user:Dr.Nuha|Nuha AL-Howthi, MD]] | *[[user:Dr.Nuha|Nuha AL-Howthi, MD]] | ||
*[[User:Nnabude|Ogechukwu Hannah Nnabude, MD]] | *[[User:Nnabude|Ogechukwu Hannah Nnabude, MD]] | ||
'''Endocrinology and COVID-19''' | |||
*'''[[User:Tayyaba Ali|Tayyaba Ali, M.D.]]''' | |||
{{ColBreak}} | {{ColBreak}} | ||
'''Frequently Asked Inpatient Questions Team Members''' | '''Frequently Asked Inpatient Questions Team Members''' | ||
| Line 86: | Line 88: | ||
*[[User:Rina Ghorpade|Rina Ghorpade, M.B.B.S.]] | *[[User:Rina Ghorpade|Rina Ghorpade, M.B.B.S.]] | ||
*[[User:Rija Gul|Rija Gul, M.B.B.S]] | *[[User:Rija Gul|Rija Gul, M.B.B.S]] | ||
'''Infectious diseases and COVID-19''' | '''Infectious diseases and COVID-19''' | ||
* [[User:Zaida Obeidat|Zaida Obeidat, M.D.]] | * [[User:Zaida Obeidat|Zaida Obeidat, M.D.]] | ||
Revision as of 21:55, 12 August 2020
| COVID-19 Project |
|---|
| Introduction |
| Team |
| Meetings' Summary |
| Topics |
| Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Meet The Team
Associate Editor(s)-in-Chief:
- The name of the leaders are written in bold: